Abstract:Vascular endothelial cells are crucial mediators of inflammation during infectious diseases, due to their ability to produce lipid-based inflammatory mediators and facilitate leukocyte migration and translocation to infected tissues. Mastitis is the costliest infectious disease in North America, with over two billion dollars in annual costs due to loss of milk production, medical treatment, and potential loss of the animal. Infections caused by coliform bacteria are particularly deleterious, causing a negative impact on cow well-being and a high mortality rate. Dysfunction and breakdown of the endothelial barrier is a key part of the pathology of coliform mastitis. The endocannabinoid system (ECS), shown to modulate inflammatory responses of vascular endothelial cells in humans and rodents, may be a novel target for inflammatory modulation in dairy cows. The endocannabinoid (EC) arachidonoylethanolamide (AEA) is a potent anti- or pro-inflammatory mediator in endothelial cells, depending on location, timing, and concentration. We hypothesized that elevated AEA during LPS challenge will impair endothelial barrier integrity via increased production of reactive oxygen species (ROS) and activation of apoptotic pathways. Challenge of bovine aortic endothelial cells (BAEC) with 25 ng/mL lipopolysaccharide (LPS) for 8 h induced AEA synthesis, increased expression of cannabinoid receptor 1 and 2 (CB1/2) and the AEA synthesizing enzyme N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD), while decreasing gene expression of the AEA degradation enzyme fatty acid amide hydrolase (FAAH). Trans endothelial resistance (TER), measured through electrical resistance across the monolayer, increased 2 h after 0.5 μM AEA treatment and decreased with 5 μM AEA, compared to LPS alone. Addition of AEA to BAEC challenged with LPS induced mitochondrial dysfunction via increased ROS production, cytochrome-C release, and activation of caspase 3/7. Antagonism of CB1 by 1 μM AM251 ameliorated AEA induced ROS production and cytochrome-C release. Addition of AM251 also eliminated 2 h TER increase and improved TER following 5 μM AEA. Doses of 0.5, 1, and 5 μM AEA delayed endothelial barrier recovery, which was eliminated by the addition of AM251. Mitochondrial dysfunction and activation of apoptotic pathways in response to AEA treatment during LPS challenge of BAEC may act to delay inflammatory resolution and contribute to endothelial dysfunction.

Differential Responses to Lipopolysaccharide Between Human and Baboon Arterial Endothelial Cells

Molecular pathways mediating differential responses to lipopolysaccharide between human and baboon arterial endothelial cells.

Comparative analysis of vascular endothelial cell activation by TNF-alpha and LPS in humans and baboons.

Comparative analysis of vascular endothelial cell activation by TNF-α and LPS in humans and baboons

Genetic Regulation of Endothelial Inflammatory Responses in Baboons

Monocytes, Peripheral Blood Mononuclear Cells, and THP-1 Cells Exhibit Different Cytokine Expression Patterns following Stimulation with Lipopolysaccharide

Profound Influence Of Ldl Oxidative Status And Monocyte Co-Cultures On Baboon Endothelial Activation

Diversity of Porphyromonad Gingivalis Lipopolysaccharide Induced IL-1β, TNF-α and IL-6 Levels in HL-60 Cells and the Associated Toll-like Receptors and Signaling Pathways

Diversity of Porphyromonas gingivalis lipopolysaccharide induced IL-1β,TNF-α and IL-6 levels in THP-1 cells and the associated Toll-like receptors

Arterial Endothelial Dysfunction In Baboons Fed A High-Cholesterol, High-Fat Diet

Comparative Transcriptome Analyses of Immune Responses to LPS in Peripheral Blood Mononuclear Cells from the Giant Panda, Human, Mouse, and Monkey

Anandamide Alters Barrier Integrity of Bovine Vascular Endothelial Cells during Endotoxin Challenge

Arterial Wall-Determined Risk Factors to Vascular Diseases: a Nonhuman Primate Model.

Comparative Transcriptome Profiles of Human Blood in Response to the Toll-like Receptor 4 Ligands Lipopolysaccharide and Monophosphoryl Lipid A

Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins.

[Different Expression of Cytokines Induced by Actinobacillus Actinomycetemcomitans Lipopolysaccharide in Monocytes/macrophages from Different Organs of Rabbits].

Repertoire of Endothelial Progenitor Cells Mobilized by Femoral Artery Ligation: A Nonhuman Primate Study

Protective Effects of Resveratrol on TNF-α-Induced Endothelial Cytotoxicity in Baboon Femoral Arterial Endothelial Cells

Differential Effects of Ruminant and Industrial 18-Carbon trans-Monounsaturated Fatty Acids (trans Vaccenic and Elaidic) on the Inflammatory Responses of an Endothelial Cell Line

Discordance of endothelial nitric oxide synthase in the arterial wall and its circulating products in baboons: interactions with redox metabolism.

Enhanced Endothelin A and B Receptor Expression and Receptor-Mediated Vasoconstriction in Rat Mesenteric Arteries after Lipopolysaccharide Challenge